Peer Comparison
| Company | Market Price | MCAP(Cr) | P/B | P/E | EPS | ROE |
|---|---|---|---|---|---|---|
| PEL | 918.9(-0.8%) | 20,815 | 0.7 | 5.3 | 11.7 | 30.0 |
| LAURUSLABS | 383.65(-1.6%) | 20,994 | 5.2 | 57.1 | 23.0 | 21.6 |
| SANOFI | 8130.2(-0.9%) | 18,894 | 22.7 | 121.2 | 59.8 | 40.8 |
| PFIZER | 4080.6(0.9%) | 18,461 | 5.3 | 134.6 | 27.6 | 20.6 |
| GLENMARK | 795.95(-3.2%) | 23,190 | 2.5 | 0.0 | 9.2 | 4.1 |
| JBCHEPHARM | 1452.8(-3.0%) | 23,232 | 8.6 | 47.7 | 17.8 | 14.9 |
| SUVENPHAR | 665.65(-2.5%) | 17,379 | 9.0 | 40.2 | 33.4 | 25.2 |
| AJANTPHARM | 1926.95(-1.6%) | 24,628 | 7.1 | 37.3 | 22.6 | 17.7 |
| APLLTD | 773.6(0.7%) | 15,097 | 3.4 | 28.4 | 7.2 | 7.1 |
| NATCOPHARM | 780.25(-0.3%) | 14,020 | 2.6 | 12.4 | 18.1 | 15.7 |
| GLAXO | 1690.1(0.1%) | 28,620 | 18.6 | 44.2 | 16.5 | 5.5 |
| IPCALAB | 1119.3(-1.2%) | 28,726 | 4.7 | 58.4 | 11.8 | 8.9 |
| GLAND | 1777.75(0.8%) | 29,042 | 3.5 | 41.6 | 14.0 | 10.3 |
| BIOCON | 239(-1.3%) | 29,073 | 1.5 | 58.3 | 16.1 | 18.0 |
| ERIS | 876.35(-2.7%) | 12,243 | 5.1 | 31.8 | 17.3 | 18.3 |
